State-of-the-art next-generation sequencing, transcriptomics, proteomics and other high- throughput 'omics' technologies enable the efficient generation of large experimental data …
Cancer Genome Atlas Research … - New England Journal of …, 2013 - Mass Medical Soc
Background Many mutations that contribute to the pathogenesis of acute myeloid leukemia (AML) are undefined. The relationships between patterns of mutations and epigenetic …
S Vandevyver, L Dejager, C Libert - Endocrine reviews, 2014 - academic.oup.com
Glucocorticoids are among the most prescribed drugs worldwide for the treatment of numerous immune and inflammatory disorders. They exert their actions by binding to the …
Background The advantages and utility of microRNAs (miRNAs) as diagnostic and prognostic cancer markers is at the vanguard in recent years. In this study, we attempted to …
Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasm driven by BCR- ABL1 oncoprotein, which plays a pivotal role in CML pathology, diagnosis, and treatment as …
B Mansoori, A Mohammadi, M Ghasabi… - Journal of cellular …, 2019 - Wiley Online Library
Background Breast cancer is the most common type of cancer among women, and despite improved treatments, it remains a major challenge. However, improved mechanistic insight …
T Isobe, S Hisamori, DJ Hogan, M Zabala… - Elife, 2014 - elifesciences.org
MicroRNAs (miRNAs) are important regulators of stem and progenitor cell functions. We previously reported that miR-142 and miR-150 are upregulated in human breast cancer …
Small non-coding microRNAs (miRNAs) are epigenetic regulators that target specific cellular mRNA to modulate gene expression patterns and cellular signaling pathways. miRNAs are …
CVA Collares, AF Evangelista, DJ Xavier, DM Rassi… - BMC research …, 2013 - Springer
Background Regardless the regulatory function of microRNAs (miRNA), their differential expression pattern has been used to define miRNA signatures and to disclose disease …